Thrombopoietin receptor agonists can be used temporarily with patients suffering from refractory chronic lymphocytic leukemia-associated immunologic thrombocytopenia

Leuk Lymphoma. 2011 Apr;52(4):724-5. doi: 10.3109/10428194.2010.551794. Epub 2011 Feb 16.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / complications*
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
  • Male
  • Middle Aged
  • Platelet Count
  • Receptors, Fc / therapeutic use*
  • Receptors, Thrombopoietin / agonists*
  • Recombinant Fusion Proteins / therapeutic use*
  • Thrombocytopenia / complications*
  • Thrombocytopenia / drug therapy*
  • Thrombopoietin / therapeutic use*
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Receptors, Fc
  • Receptors, Thrombopoietin
  • Recombinant Fusion Proteins
  • Thrombopoietin
  • romiplostim